New Zealand markets open in 8 hours 53 minutes

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
310.88-6.97 (-2.19%)
At close: 04:00PM EST
312.10 +1.22 (+0.39%)
After hours: 06:10PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
3,426,100
2,923,933
2,621,226
2,266,096
Cost of revenue
2,138,606
1,850,392
1,662,915
1,426,029
Gross profit
1,287,494
1,073,541
958,311
840,067
Operating expenses
Selling general and administrative
618,840
528,935
517,622
443,854
Total operating expenses
741,512
640,812
607,160
508,684
Operating income or loss
545,982
432,729
351,151
331,383
Interest expense
95,511
86,433
60,882
63,772
Total other income/expenses net
38,618
99,984
12,293
13,258
Income before tax
489,495
447,114
304,084
281,681
Income tax expense
86,295
81,808
50,023
54,463
Income from continuing operations
403,200
365,306
254,061
227,218
Net income
396,595
364,304
252,019
226,373
Net income available to common shareholders
396,595
364,304
252,019
226,373
Basic EPS
-
7.35
5.17
4.72
Diluted EPS
-
7.20
5.07
4.62
Basic average shares
-
49,550
48,730
47,947
Diluted average shares
-
50,611
49,693
49,018
EBITDA
-
768,471
563,061
507,232